Guardant Health
GH
#2715
Rank
โ‚น422.15 B
Marketcap
โ‚น3,420
Share price
9.50%
Change (1 day)
117.66%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

Guardant Health (GH) - Total debt

Total debt on the balance sheet as of December 2024 : โ‚น116.43 Billion

According to Guardant Health 's latest financial reports the company's total debt is โ‚น116.43 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Guardant Health - Total debt on balance sheet (from 2017 to 2024)

Total debt by year

Year Total debt Change
2024-12-31โ‚น114.61 B1.7%
2023-12-31โ‚น112.69 B-0.54%
2022-12-31โ‚น113.30 B10.82%
2021-12-31โ‚น102.24 B63.62%
2020-12-31โ‚น62.49 B2069.36%
2019-12-31โ‚น2.88 B
2018-12-31N/A-100%
2017-12-31โ‚น42.07 M-96.37%
2016-12-31โ‚น1.15 B

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
โ‚น16.30 B-85.99%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น77.77 B-33.20%๐Ÿ‡บ๐Ÿ‡ธ USA